Subscribe To
ACAD / Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up
![Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up](https://cdn.snapi.dev/images/v1/7/j/2216-2139055.jpg)
ACAD News
![Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up](https://cdn.snapi.dev/images/v1/7/j/2216-2139055.jpg)
By Zacks Investment Research
November 3, 2023
Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up
Acadia (ACAD) reports better-than-expected third-quarter 2023 results as both earnings and sales beat estimates. The stock rises in after-market hours more_horizontal
![ACADIA Pharmaceuticals Inc. (ACAD) Q3 2023 Earnings Call Transcript ACADIA Pharmaceuticals Inc. (ACAD) Q3 2023 Earnings Call Transcript](https://cdn.snapi.dev/images/v1/6/x/transcript46-2138446.jpg)
By Seeking Alpha
November 3, 2023
ACADIA Pharmaceuticals Inc. (ACAD) Q3 2023 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Jessica Tieszen - Associa more_horizontal
![Reasons to Add Acadia (ACAD) Stock to Your Portfolio Now Reasons to Add Acadia (ACAD) Stock to Your Portfolio Now](https://cdn.snapi.dev/images/v1/u/e/5473-2101376.jpg)
By Zacks Investment Research
October 12, 2023
Reasons to Add Acadia (ACAD) Stock to Your Portfolio Now
Here we discuss some reasons why investing in Acadia (ACAD) stock now may turn out to be a more prudent move than ever. more_horizontal
![2 Growth Stocks I'd Buy on the Dip 2 Growth Stocks I'd Buy on the Dip](https://cdn.snapi.dev/images/v1/k/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f7493032fu-turnjpgopresizew400h400-2084843.jpg)
By The Motley Fool
September 30, 2023
2 Growth Stocks I'd Buy on the Dip
September hasn't been overly kind to growth stocks. This latest bout of volatility, however, may have created some compelling buying opportunities. more_horizontal
![Acadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains? Acadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains?](https://cdn.snapi.dev/images/v1/g/i/default253-2081351.jpg)
By Zacks Investment Research
September 28, 2023
Acadia (ACAD) Surges 8.3%: Is This an Indication of Further Gains?
Acadia (ACAD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions more_horizontal
![Acadia stock price analysis: ACAD risk/reward is attractive Acadia stock price analysis: ACAD risk/reward is attractive](https://cdn.snapi.dev/images/v1/e/k/125419969-s-2080904.jpg)
By Invezz
September 27, 2023
Acadia stock price analysis: ACAD risk/reward is attractive
Acadia Pharmaceuticals (NASDAQ: ACAD) stock price did well on Wednesday even as American equities retreated. The biotech stock jumped to a high of $26 more_horizontal
![Acadia Pharmaceuticals: Difficult Market Masks Progress Acadia Pharmaceuticals: Difficult Market Masks Progress](https://cdn.snapi.dev/images/v1/6/w/image-1417761158-2077455.jpg)
By Seeking Alpha
September 26, 2023
Acadia Pharmaceuticals: Difficult Market Masks Progress
Acadia Pharmaceuticals' gains recently disappeared despite the strong launch of Daybue. Poor market conditions are to blame, especially the poor biote more_horizontal
![Daybue Drives Acadia Pharmaceuticals To Positive Earnings (Rating Upgrade) Daybue Drives Acadia Pharmaceuticals To Positive Earnings (Rating Upgrade)](https://cdn.snapi.dev/images/v1/p/d/image-1398237718-2075334.jpg)
By Seeking Alpha
September 23, 2023
Daybue Drives Acadia Pharmaceuticals To Positive Earnings (Rating Upgrade)
Acadia Pharmaceuticals shows fiscal resilience with a shift to net positive income, buoyed by Daybue's strong Q2 debut and increased Nuplazid sales. D more_horizontal